Aflac Incorporated is an insurance company that provides supplemental health and life insurance products in Japan and the United States. The company operates through two reporting segments: Aflac Japan and Aflac U.S. In Japan, Aflac Life Insurance Japan Ltd. offers third-sector insurance products, including cancer insurance and medical coverage, designed to cover out-of-pocket expenses not reimbursed by the national health insurance system. In the U.S., subsidiaries such as American Family Life Assurance Company of Columbus, Continental American Insurance Company, and American Family Life Assurance Company of New York provide voluntary and employer-paid health and life insurance, dental, and vision benefits. The company sells its products through agents, brokers, distribution partners, and direct channels. Aflac Japan is the largest insurer in Japan for cancer and medical third-sector insurance policies. The company was incorporated in 1973 and uses the Aflac Duck as a marketing icon in both the U.S. and Japan.

Summarised from the company's own disclosures, fiscal year ended Feb 2026

Industry Insurance - Life Homepage aflac.com
Sector Financial Services IR page investors.aflac.com/home/default.aspx
Tags
supplemental insurance, cancer insurance, medical insurance, dental insurance, vision insurance, life insurance, group insurance, voluntary benefits, third-sector insurance, Aflac Japan, Aflac U.S., Aflac Life Insurance Japan Ltd., American Family Life Assurance Company of Columbus, Continental American Insurance Company, Aflac Group Insurance, American Family Life Assurance Company of New York, Tier One Insurance Company, Aflac Benefits Solutions Inc., Aflac Dental and Vision, Aflac Duck, Miraito
Press page —

Metrics

Valuation  
Market cap $ 63.632B
Market cap (USD) $ 63.632B
P/E 18.88
PEG —
P/BV 2.17
P/S 3.83
P/OCF 24.55
P/FCF 24.90
Dividend yield 1.8%
Turnover / mcap —
Returns  
ROE 13.1%
ROI 9.6%
ROIC 9.6%
Profit margin 21.2%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y No
Earnings growth 3y (net profit CAGR) -4.6%
Quality  
Profitable Yes
Margin expanding No
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 17
Quality score -10.5%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Revenue 17.164B 18.927B 18.701B 19.502B 22.106B 22.147B 22.307B 21.758B 21.667B 22.559B 20.872B 22.728B 23.939B 25.364B 22.171B 20.732B 18.254B 16.554B 15.393B 14.616B 14.363B 13.281B — — 9.598B 9.703B
Net profit 3.646B 5.443B 4.659B 4.201B 4.325B 4.778B 3.304B 2.92B 4.604B 2.659B 2.533B 2.951B 3.158B 2.866B 1.964B 2.344B 1.497B 1.254B 1.634B 1.483B 1.483B 1.299B 795M 821M 687M 687M
Free cash flow 2.555B 2.707B 3.19B 3.879B 5.051B — — — — — — — — — — — — 4.916B 4.61B 4.374B 4.417B 4.465B 3.368B 3.013B 2.804B 3.219B

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000
Share price 110.27 103.44 82.5 71.94 58.39 44.47 52.9 45.56 87.78 69.6 59.9 61.09 66.8 53.12 43.24 56.44 46.25 45.84 61.97 44.05 47.98 — — — — —
Price performance 12m 0.07 0.25 0.15 0.23 0.31 -0.16 0.16 -0.48 0.26 0.16 -0.02 -0.09 0.26 0.23 -0.23 0.22 0.01 -0.26 0.41 -0.08 — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Lease liabilities (USD) — — 0.00 149M 143M 105M 139M 118M 91M 73M
Cash and deposits (USD) 4.86B 3.49B 4.34B 4.9B 5.14B 5.05B 3.94B 4.31B 6.23B 6.25B
Cash flow detail
Operating cash flow (USD) 5.99B 6.13B 6.01B 5.46B 5.96B 5.05B 3.88B 3.19B 2.71B 2.56B
Change in receivables (cash effect) (USD) 42M -91M -55M -32M 52M 72M 2M -133M 51M -66M
Dividends paid (cash effect) (USD) -658M -661M -793M -771M -769M -855M -979M -966M -1.09B -1.2B
Share buybacks (cash effect) (USD) -1.42B -1.35B -1.3B -1.63B -1.54B -2.3B -2.4B -2.8B -2.8B -3.53B
Interest paid (cash effect) (USD) -211M -196M -181M -190M -210M -213M -211M -185M -180M -197M
Income taxes paid (cash effect) (USD) -1.53B -780M -998M -1.38B -800M -880M -961M -1.57B -1.37B -1.17B
Operating cash flow before change in receivables (USD) 5.95B 6.22B 6.07B 5.49B 5.91B 4.98B 3.88B 3.32B 2.66B 2.62B
Income detail
Total comprehensive income (USD) 4.66B 6B 817M 7.77B 6.25B 2.78B -7.6B 5.57B 7.99B 8.08B
Comprehensive income to owners (USD) 4.66B 6B 817M 7.77B 6.25B 2.78B -7.6B 5.57B 7.99B 8.08B
Reported Feb 24, 2017 Feb 23, 2018 Apr 26, 2019 Feb 21, 2020 Feb 23, 2021 Feb 23, 2022 Feb 24, 2023 Feb 22, 2024 Feb 26, 2025 Feb 25, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Every day, countless people stand in front of a mirror, making simple yet meaningful decisions about how they want to look. Whether it's jeans, a necktie or a skirt they reach for, the colors they pair, the accessories they wear or the shoes they choose, every element contributes to a look that reflects their personality, confidence and self-expression.

As part of the broader Check for Cancer movement, the next evolution, Fit Checks, offers a fresh perspective on a familiar trend. Instead of focusing solely on what people wear, it encourages individuals to view everyday style through a different lens, connecting self-expression with the importance of prioritizing health. The initiative transforms fashion into an opportunity to encourage people to prioritize recommended cancer screenings. It’s fashion with a purpose.

Fit Checks: When a fashion trend becomes fashion with a purpose
The term "fit check" has become a cultural phenomenon. Derived from "outfit check," the viral social media trend invites people to share what they're wearing, highlighting the details that come together to create a complete look.

At its core, a fit check is about drawing attention to what's visible.

For Aflac, however, the trend presented an opportunity to spotlight something that often you cannot see — checking your health.

As a pioneer in cancer insurance, Aflac has spent seven decades helping individuals and families navigate emotional and financial challenges that can come with a cancer diagnosis. That history reinforces a reality that remains as important today as ever: early detection can help save lives.

Unfortunately, between work responsibilities, family commitments and other demands of everyday life, preventive care can easily fall lower on the priority list. In fact, roughly 3 in 5 Americans admit to avoiding important health checkups.1

Cancer screenings, however, can play an important role in early detection. The challenge isn't always awareness. Often, it's taking the next step, and that’s where reminders can make a difference.

Some reminders come from a physician's office. Others come from loved ones. Fit Checks explores the possibility that reminders can also come from unexpected places — a checkered pattern, a social media trend or a moment spent standing in front of the mirror before heading out the door.

Turning the checkered pattern into a Check for Cancer
To bring the idea to life, Aflac partnered with renowned celebrity fashion stylist Rachel Zoe to transform a familiar pattern into an unexpected reminder to check in on yourself.

Together, they elevated the classic checkered pattern beyond a fashion statement, creating a conversation starter designed to make people pause, lean in and think differently about cancer screenings.

The result was a first-of-its-kind jacket featuring a QR code embedded directly into the checkered pattern, transforming an everyday garment into an interactive cancer screening assessment tool .

"At first glance, someone might simply see a stylish jacket. But a closer look tells a different story," Aflac Incorporated Senior Vice President and Chief Communications Officer Ines  Rodriguez Gutzmer said. "Fit Checks is about meeting people where they are, and by leveraging a fashion trend, we're helping make conversations about cancer screenings more approachable, more visible and harder to ignore."

Individuals can access a cancer screening assessment  tool and learn more about recommended screenings that may be right for them by scanning the checkered pattern or visiting www.CheckForCancerNow.com .


1 Aflac. “2026 Wellness Matters Survey overview .” Published August 2026.

Aflac WWHQ | 1932 Wynnton Road | Columbus, GA 31999

Z2600865 EXP 1/27

Share Page Close

Facebook Twitter Google+

© 2026 AFLAC INCORPORATED

VIEW LEGAL

Individual Policies:
Coverage underwritten by American Family Life Assurance Company of Columbus. In New York, coverage underwritten by American Family Life Assurance Company of New York. Direct to Consumer individual coverage underwritten by Tier One Insurance Company.

Aflac Worldwide Headquarters | Columbus, GA

Aflac Group Policies:
Continental American Insurance Company (CAIC), a proud member of the Aflac family of insurers, is a wholly-owned subsidiary of Aflac Incorporated and underwrites group coverage. CAIC is not licensed to solicit business in New York, Guam, Puerto Rico, or the Virgin Islands. For groups sitused in California, group coverage is underwritten by Continental American Life Insurance Company. For groups sitused in New York, coverage is underwritten by American Family Life Assurance Company of New York.

Aflac Group | Columbia, SC

“Aflac” may include American Family Life Assurance Company of Columbus, American Family Life Assurance Company of New York, Continental American Insurance Company (marketed as “Aflac Group”), Tier One Insurance Company, and any other affiliated companies (collectively, “Aflac”), as applicable to the entity from whom you receive insurance services.

© 2026 000

 (opens in a new window)

11/04/2026

Download this Press Release PDF Format (opens in new window)

COLUMBUS, Ga., Nov. 4, 2026 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) today reported its third quarter results.

For the Quarter

  • Net earnings were $303 million, or $0.61 per diluted share, compared with $1.6 billion, or $3.08 per diluted share a year ago.
  • Adjusted earnings* were $1.2 billion, compared with $1.3 billion a year ago, reflecting a decrease of 8.5%.
  • Adjusted earnings per diluted share* decreased 2.4% to $2.43.
  • Adjusted earnings benefited from reserve remeasurement gains of $453 million.
  • Annualized return on average shareholders' equity was 4.1%.
  • Annualized adjusted return on equity excluding foreign currency remeasurement* was 23.7%.
  • The Company returned $1.1 billion to shareholders, consisting of $804 million in share repurchase and $305 million in dividends.
  • Aflac Incorporated reached the milestone of 44 consecutive years of dividend increases with the fourth quarter declaration of $0.61.
  • Aflac Japan ceded approximately ¥500 billion of reserves on an FSA basis associated with cancer insurance policies to Aflac Re Bermuda.

Commenting on the company's results, Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos stated: "Aflac delivered solid adjusted earnings for the quarter and for the first nine months. These results demonstrate our drive to execute our strategy and create long-term value for our shareholders. In Japan, we have continued to address our customers' needs at different life stages through products including Anshin Palette (medical insurance), Miraito (cancer insurance) and Tsumitasu (savings-type life insurance). In addition, the Aflac Japan results reflect the impact of our reinsurance strategy on the income statement included within Corporate and Other results, where Aflac Re Bermuda is consolidated. In the U.S., our focus remains on meeting the evolving needs of employers and their employees with supplemental health products and related benefits.

"We remain focused on more profitable growth and the tactical, opportunistic deployment of capital. We treasure our 2026 milestone of 44 consecutive years of dividend increases. We continue to deploy our balanced approach of investing in growth and driving long-term value while being there for our policyholders when they need us most."

AFLAC INCORPORATED CONSOLIDATED RESULTS

AFLAC INCORPORATED SELECTED OPERATING RESULTS FOR THE QUARTER
(IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)
3Q26 3Q25 % Change
Total revenues $   3,271 $   4,740 (31.0) %
Net earnings 303 1,639 (81.5) %
Adjusted earnings* 1,214 1,327 (8.5) %
Net earnings per share (diluted) 0.61 3.08 (80.2) %
Adjusted earnings per share (diluted)* 2.43 2.49 (2.4) %
Total shareholders' equity 29,283 28,688 2.1 %
Total liabilities and shareholders' equity 113,511 122,306 (7.2) %

Total revenues were $3.3 billion in the third quarter of 2026, compared with $4.7 billion in the third quarter of 2025. Net earnings were $303 million, or $0.61 per diluted share, compared with $1.6 billion, or $3.08 per diluted share a year ago, primarily due to realized losses associated with the strategic repositioning of the portfolio during the third quarter. In addition, net earnings in the third quarter of 2026 included a $51 million, or $0.10 per diluted share, tax capital loss valuation allowance established against a portion of the Company's deferred tax assets associated with tax capital loss carryforwards. Net earnings in the third quarter of 2026 also included net investment losses of $1.1 billion, or $2.15 per diluted share, compared with net investment gains of $275 million, or $0.52 per diluted share a year ago. These net investment losses include net losses from sales and redemptions of $842 million; net losses of $146 million on certain derivatives and foreign currency activities; $102 million of current expected credit losses (CECL); and impairments of $1 million; offset by a $19 million gain from an increase in the fair value of equity securities.

Adjusted earnings* in the third quarter were $1.2 billion, compared with $1.3 billion in the third quarter of 2025, reflecting a decrease of 8.5%. Adjusted earnings per diluted share* decreased 2.4% to $2.43 in the quarter. The average yen/dollar exchange rate in the third quarter of 2026 was 158.49, or 6.8% weaker than the average rate of 147.68 in the third quarter of 2025. The weaker yen/dollar exchange rate had a negative $0.03 impact on adjusted earnings per share.

Shareholders' equity was $29.3 billion, or $59.08 per share, at September 30, 2026, compared with $28.7 billion, or $54.57 per share, at September 30, 2025. Shareholders' equity at the end of the third quarter included a cumulative increase of $12.3 billion for the effect of the change in discount rate assumptions on insurance reserves, compared with a corresponding cumulative increase of $6.8 billion at September 30, 2025 and a net unrealized loss on investment securities and derivatives of $5.0 billion, compared with a net unrealized loss of $1.7 billion at September 30, 2025. Shareholders' equity at the end of the third quarter also included an unrealized foreign currency translation loss of $4.9 billion, compared with an unrealized foreign currency translation loss of $4.5 billion at September 30, 2025.

For the first nine months of 2026, total revenues were down 4.6% to $11.7 billion, compared with $12.3 billion in the first nine months of 2025. Net earnings were $2.1 billion, or $4.24 per diluted share, compared with $2.3 billion, or $4.21 per diluted share, for the first nine months of 2025. Adjusted earnings for the first nine months of 2026 were $3.0 billion, or $5.92 per diluted share, compared with $3.2 billion, or $5.92 per diluted share, in 2025. For the first nine months, the average exchange rate was 158.28, or 6.5% weaker than the rate of 148.03 a year ago. Excluding the negative impact of $0.10 per share from the weaker yen/dollar exchange rate, adjusted earnings per diluted share increased 1.7% to $6.02 for the first nine months of 2026.

Shareholders' equity excluding accumulated other comprehensive income (AOCI), or adjusted book value,* was $26.9 billion, or $54.21 per share at September 30, 2026, compared with $28.0 billion, or $53.33 per share, at September 30, 2025. Adjusted book value excluding foreign currency remeasurement* was $20.2 billion, or $40.73 per share at September 30, 2026, compared with $22.9 billion, or $43.52 per share, at September 30, 2025. The annualized adjusted return on equity excluding foreign currency remeasurement* in the third quarter was 23.7%.

AFLAC JAPAN

AFLAC JAPAN SELECTED OPERATING RESULTS FOR THE QUARTER
(IN BILLIONS OF YEN AND MILLIONS OF DOLLARS)
3Q26 3Q25 % Change 3Q26 3Q25 % Change
Total net earned premiums ¥  240 ¥   245 (2.0) % $   1,508 $   1,663 (9.3) %
Yen-denominated investment income 33 32 2.2 % 205 217 (5.5) %
U.S. dollar-denominated investment income 71 68 4.0 % 445 461 (3.5) %
Adjusted net investment income 102 98 3.7 % 639 665 (3.9) %
Total adjusted revenues 343 344 (0.3) % 2,156 2,335 (7.7) %
Total benefits and claims, net 118 96 22.5 % 737 656 12.3 %
Total adjusted expenses 73 68 6.6 % 458 463 (1.1) %
Pretax adjusted earnings 152 180 (15.2) % 961 1,216 (21.0) %
Change in bps
Premium persistency (12-mo. rolling) 92.9 % 93.3 % (40)
Total benefits and claims, net / Total net earned premiums 49.2 % 39.3 % 990
Total adjusted expenses / Total adjusted revenues 21.2 % 19.8 % 140
Pretax adjusted earnings / Total adjusted revenues 44.4 % 52.2 % (780)

In yen terms, Aflac Japan's net earned premiums were ¥240.3 billion for the quarter, or 2.0% lower than a year ago, mainly due to the combined impact of an external reinsurance transaction effective during the first quarter and an internal reinsurance transaction on blocks of cancer insurance effective during the third quarter, as well as limited pay products reaching paid-up status. Adjusted net investment income increased 3.7% to ¥101.6 billion, primarily due to higher fixed-rate income and higher income on U.S. dollar-denominated assets from the weakening yen; offset by lower floating-rate income and higher expenses. Total adjusted revenues in yen declined 0.3% to ¥343.2 billion. Pretax adjusted earnings in yen for the quarter declined 15.2% on a reported basis to ¥152.3 billion, primarily driven by higher benefits due to lower reserve remeasurement gains as a result of unlocking actuarial assumptions, compared to the previous year. Pretax adjusted earnings decreased 17.9% on a currency-neutral basis. The pretax adjusted profit margin for the Japan segment was 44.4%, compared with 52.2% a year ago.

For the first nine months, net earned premiums in yen were ¥732.1 billion, or 3.2% lower than a year ago. Adjusted net investment income increased 1.5% to ¥292.7 billion. Total adjusted revenues in yen were down 1.9% to ¥1.0 trillion. Pretax adjusted earnings were ¥389.7 billion, or 3.5% lower than a year ago. As a result, the pretax adjusted profit margin for the Japan segment was 37.9%, compared with 38.5% a year ago.

In dollar terms, net earned premiums decreased 9.3% to $1.5 billion in the third quarter. Adjusted net investment income decreased 3.9% to $639 million. Total adjusted revenues declined by 7.7% to $2.2 billion. Pretax adjusted earnings declined 21.0% to $961 million.

For the first nine months, net earned premiums in dollars were $4.6 billion, or 9.5% lower than a year ago. Adjusted net investment income decreased 5.3% to $1.8 billion. Total adjusted revenues were down 8.3% to $6.5 billion. Pretax adjusted earnings were $2.5 billion, or 9.8% lower than a year ago.

For the quarter, total new annualized premium sales (sales) decreased 4.0% to ¥18.8 billion, or $118 million, reflecting high prior-year sales for Miraito cancer insurance following its launch in March 2025, partially offset by solid growth in the Tsumitasu savings-type life insurance refreshed in the second quarter of 2026 and Anshin Palette, the medical insurance product launched in December 2025. For the first nine months, sales increased 3.0% to ¥56.1 billion, or $354 million.

AFLAC U.S.

AFLAC U.S. SELECTED OPERATING RESULTS FOR THE QUARTER
(IN MILLIONS OF DOLLARS)
3Q26 3Q25 % Change
Total net earned premiums $ 1,544 $ 1,495 3.3 %
Adjusted net investment income 212 214 (0.9) %
Total adjusted revenues 1,781 1,728 3.1 %
Total benefits and claims, net 629 681 (7.6) %
Total adjusted expenses 659 672 (1.9) %
Pretax adjusted earnings 493 375 31.5 %
**Change **in bps
Premium persistency (12-mo. rolling) 79.7 % 79.0 % 70
Total benefits and claims, net / Total net earned premiums 40.7 % 45.6 % (490)
Total adjusted expenses / Total adjusted revenues 37.0 % 38.9 % (190)
Pretax adjusted earnings / Total adjusted revenues 27.7 % 21.7 % 600

Aflac U.S. net earned premiums increased 3.3% to $1.5 billion in the third quarter compared to the prior year, reflecting improved sales and strong persistency. Adjusted net investment income decreased 0.9% to $212 million. Total adjusted revenues were up 3.1% to $1.8 billion. Pretax adjusted earnings were $493 million, 31.5% higher than a year ago, primarily driven by lower benefits from higher reserve remeasurement gains as a result of unlocking actuarial assumptions and higher premiums as well as lower expenses. The pretax adjusted profit margin for the U.S. segment was 27.7%, compared with 21.7% a year ago.

For the first nine months, net earned premiums increased 3.0% to $4.6 billion. Adjusted net investment income remained relatively flat at $621 million. Total adjusted revenues were up 3.0% to $5.3 billion. Pretax adjusted earnings were $1.2 billion, 9.4% higher than a year ago. As a result, the pretax adjusted profit margin for the U.S. segment was 23.0%, compared with 21.7% a year ago.

Aflac U.S. sales increased 3.5% in the quarter to $403 million, primarily benefiting from sales of network dental as well as group life and disability products. For the first nine months, total new sales increased 3.1% to $1.1 billion.

CORPORATE AND OTHER 

CORPORATE AND OTHER SELECTED OPERATING RESULTS
(IN MILLIONS OF DOLLARS)
3Q26 3Q25 % Change
Total net earned premiums $      252 $      214 17.8 %
Adjusted net investment income 106 130 (18.5) %
Total adjusted revenues 360 343 5.0 %
Total benefits and claims, net 73 99 (26.3) %
Interest expense 67 55 21.8 %
Other adjusted expenses 148 120 23.3 %
Total benefits and adjusted expenses 288 274 5.1 %
Pretax adjusted earnings 72 69 4.3 %

For the quarter, total adjusted revenues increased 5.0% to $360 million. Pretax adjusted earnings were $72 million, compared with $69 million last year, primarily driven by higher reserve remeasurement gains as a result of unlocking actuarial assumptions and new reinsurance transactions. These earnings results were impacted by higher total adjusted expenses, as well as lower adjusted net investment income from reduced short-term asset balances and a smaller hedge program.

For the first nine months, total adjusted revenues decreased 6.2% to $943 million. Pretax adjusted earnings were  $62 million, compared with $132 million a year ago.

SHAREHOLDER DIVIDEND

The board of directors declared the fourth quarter dividend of $0.61 per share, payable on December 1, 2026 to shareholders of record at the close of business on November 18, 2026.

*See Non-U.S. GAAP Financial Measures section for an explanation of foreign exchange and its impact on the financial statements and definitions of the non-U.S. GAAP financial measures used in this earnings release, as well as a reconciliation of such non-U.S. GAAP financial measures to the most comparable U.S. GAAP financial measures.

ABOUT AFLAC INCORPORATED

Aflac Incorporated (NYSE: AFL), a Fortune 500 company, has helped provide financial protection and peace of mind for more than seven decades to millions of policyholders and customers through its subsidiaries in the U.S. and Japan. In the U.S., Aflac is the No. 1 provider of supplemental health insurance products.1 In Japan, Aflac Life Insurance Japan is the leading provider of cancer and medical insurance in terms of policies in force.2 The company takes pride in being there for its policyholders when they need us most, as well as being included in the World's Most Ethical Companies by Ethisphere for 20 consecutive years (2026) and Fortune's World's Most Admired Companies for 25 years (2026). In addition, the company became a signatory of the Principles for Responsible Investment (PRI) in 2021. To find out how to get help with expenses health insurance doesn't cover, get to know us at aflac.com or aflac.com/espanol .

1 LIMRA 2025 U.S. Supplemental Health Insurance Total Market Report
2 As of March 31, 2025, Aflac estimates based on company data

Aflac Incorporated periodically provides information for investors on its corporate website, investors.aflac.com , including information regarding its commitment to corporate social responsibility and sustainability, press releases, financial information, SEC filings, corporate governance materials, annual meeting information, and other information that may be important to investors.

A copy of Aflac's financial supplement for the quarter can be found at investors.aflac.com .

Aflac Incorporated will webcast its third quarter 2026 earnings conference call on Thursday, November 5, 2026 at 8:00 a.m. (ET).

Note: Tables within this document may not foot due to rounding.

AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)
THREE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Total revenues $   3,271 $   4,740 (31.0) %
Benefits and claims, net 1,439 1,436 0.2
Total acquisition and operating expenses 1,332 1,310 1.7
Earnings before income taxes 500 1,994 (74.9)
Income taxes 197 355
Net earnings $      303 $   1,639 (81.5) %
Net earnings per share – basic $     0.61 $     3.09 (80.3) %
Net earnings per share – diluted 0.61 3.08 (80.2)
Shares used to compute earnings per share (000):
Basic 496,976 530,050 (6.2) %
Diluted 498,684 532,015 (6.3)
Dividends paid per share $     0.61 $     0.58 5.2 %
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED INCOME STATEMENT
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)
NINE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Total revenues $ 11,734 $ 12,298 (4.6) %
Benefits and claims, net 5,123 5,391 (5.0)
Total acquisition and operating expenses 3,891 3,946 (1.4)
Earnings before income taxes 2,720 2,961 (8.1)
Income taxes 573 694
Net earnings $  2,147 $  2,267 (5.3) %
Net earnings per share – basic $    4.25 $    4.22 0.7 %
Net earnings per share – diluted 4.24 4.21 0.7
Shares used to compute earnings per share (000):
Basic 504,664 537,095 (6.0) %
Diluted 506,285 539,052 (6.1)
Dividends paid per share $    1.83 $    1.74 5.2 %
AFLAC INCORPORATED AND SUBSIDIARIES CONDENSED BALANCE SHEET
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AMOUNTS)
SEPTEMBER 30, 2026 2025 % Change
Assets:
Total investments and cash $ 100,433 $ 109,516 (8.3) %
Deferred policy acquisition costs 9,186 9,216 (0.3)
Other assets 3,892 3,574 8.9
Total assets $ 113,511 $ 122,306 (7.2) %
Liabilities and shareholders' equity:
Policy liabilities $  63,517 $  74,737 (15.0) %
Notes payable and lease obligations 8,900 8,685 2.5
Other liabilities 11,811 10,196 15.8
Shareholders' equity 29,283 28,688 2.1
Total liabilities and shareholders' equity $ 113,511 $ 122,306 (7.2) %
Shares outstanding at end of period (000) 495,651 525,710 (5.7) %

NON-U.S. GAAP FINANCIAL MEASURES

This document includes references to the Company's financial performance measures which are not calculated in accordance with United States generally accepted accounting principles (U.S. GAAP) (non-U.S. GAAP). The financial measures exclude items that the Company believes may obscure the underlying fundamentals and trends in insurance operations because they tend to be driven by general economic conditions and events or related to infrequent activities not directly associated with insurance operations.

Due to the size of Aflac Japan, where the functional currency is the Japanese yen, fluctuations in the yen/dollar exchange rate can have a significant effect on reported results. In periods when the Japanese yen weakens, translating Japanese yen into U.S. dollars results in fewer U.S. dollars being reported. When the Japanese yen strengthens, translating Japanese yen into U.S. dollars results in more U.S. dollars being reported. Consequently, Japanese yen weakening has the effect of suppressing current period results in relation to the comparable prior period, while Japanese yen strengthening has the effect of magnifying current period results in relation to the comparable prior period. A significant portion of the Company's business is conducted in Japanese yen and never converted into U.S. dollars but translated into U.S. dollars for U.S. GAAP reporting purposes, which results in foreign currency impact to earnings, cash flows and book value on a U.S. GAAP basis. Management evaluates the Company's financial performance both including and excluding the impact of foreign currency translation to monitor, respectively, cumulative currency impacts and the currency-neutral operating performance over time. The average yen/dollar exchange rate is based on the published MUFG Bank, Ltd. telegraphic transfer middle rate (TTM).

The company defines the non-U.S. GAAP financial measures included in this earnings release as follows:

  • Adjusted earnings are adjusted revenues less benefits and adjusted expenses. Adjusted earnings per share (basic or diluted) are the adjusted earnings for the period divided by the weighted average outstanding shares (basic or diluted) for the period presented. The adjustments to both revenues and expenses account for certain items that are outside of management's control because they tend to be driven by general economic conditions and events or are related to infrequent activities not directly associated with insurance operations. Adjusted revenues are U.S. GAAP total revenues excluding adjusted net investment gains and losses. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest from derivatives associated with notes payable but excluding any non-recurring or other items not associated with the normal course of the Company's insurance operations and that do not reflect the Company's underlying business performance. Management uses adjusted earnings and adjusted earnings per diluted share to evaluate the financial performance of the Company's insurance operations on a consolidated basis and believes that a presentation of these financial measures is vitally important to an understanding of the underlying profitability drivers and trends of the Company's insurance business. The most comparable U.S. GAAP financial measures for adjusted earnings and adjusted earnings per share (basic or diluted) are net earnings and net earnings per share, respectively.

  • Adjusted earnings excluding current period foreign currency impact are computed using the average foreign exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign exchange rate changes. Adjusted earnings per diluted share excluding current period foreign currency impact is adjusted earnings excluding current period foreign currency impact divided by the weighted average outstanding diluted shares for the period presented. The Company considers adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact important because a significant portion of the Company's business is conducted in Japan and foreign exchange rates are outside management's control; therefore, the Company believes it is important to understand the impact of translating foreign currency (primarily Japanese yen) into U.S. dollars. The most comparable U.S. GAAP financial measures for adjusted earnings excluding current period foreign currency impact and adjusted earnings per diluted share excluding current period foreign currency impact are net earnings and net earnings per share, respectively.

  • Adjusted return on equity is annualized adjusted earnings divided by average shareholders' equity, excluding accumulated other comprehensive income. Management uses adjusted return on equity to evaluate the financial performance of the Company's insurance operations on a consolidated basis and believes that a presentation of this financial measure is vitally important to an understanding of the underlying profitability drivers and trends of the Company's insurance business. The Company considers adjusted return on equity important as it excludes components of accumulated other comprehensive income, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity is return on equity as determined using annualized net earnings and average total shareholders' equity.

  • Adjusted return on equity excluding foreign currency remeasurement is annualized adjusted earnings divided by average shareholders' equity, excluding both accumulated other comprehensive income and the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The Company considers adjusted return on equity excluding foreign currency remeasurement important because it excludes both accumulated other comprehensive income and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measure for adjusted return on equity excluding foreign currency remeasurement is return on equity as determined using annualized net earnings and average total shareholders' equity.

  • Amortized hedge costs/income represent costs/income incurred or recognized as a result of using foreign currency derivatives to hedge certain foreign currency exchange risks. These amortized hedge costs/income are estimated at the inception of the derivatives based on the specific terms of each contract and are recognized on a straight-line basis over the contractual term of the derivative. The Company believes that amortized hedge costs/income measure the periodic currency risk management costs/income related to hedging certain foreign currency exchange risks and are an important component of net investment income. There is no comparable U.S. GAAP financial measure for amortized hedge costs/income.

  • Adjusted book value is the U.S. GAAP book value (representing total shareholders' equity), less accumulated other comprehensive income as recorded on the U.S. GAAP balance sheet. Adjusted book value per common share is adjusted book value at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value and adjusted book value per common share important as they exclude accumulated other comprehensive income, which fluctuates due to market movements that are outside management's control. The most comparable U.S. GAAP financial measures for adjusted book value and adjusted book value per common share are total book value and total book value per common share, respectively.

  • Adjusted book value excluding foreign currency remeasurement is the U.S. GAAP book value (representing total shareholders' equity), less accumulated other comprehensive income as recorded on the U.S. GAAP balance sheet and excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. Adjusted book value excluding foreign currency remeasurement per common share is adjusted book value excluding foreign currency remeasurement at the period end divided by the ending outstanding common shares for the period presented. The Company considers adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share important as they exclude both accumulated other comprehensive income and the cumulative foreign currency remeasurement gains/losses, which fluctuate due to market movements that are outside management's control. The most comparable U.S. GAAP financial measures for adjusted book value excluding foreign currency remeasurement and adjusted book value excluding foreign currency remeasurement per common share are total book value and total book value per common share, respectively.

  • Adjusted net investment income is net investment income adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, and ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are reclassified from net investment gains and losses to net investment income. The Company considers adjusted net investment income important because it provides a more comprehensive understanding of the costs and income associated with the Company's investments and related hedging strategies. The most comparable U.S. GAAP financial measure for adjusted net investment income is net investment income.

  • Adjusted net investment gains and losses are net investment gains and losses adjusted for i) amortized hedge cost/income related to foreign currency exposure management strategies and certain derivative activity, ii) net interest income/expense from foreign currency and interest rate derivatives associated with certain investment strategies, which are both reclassified to net investment income, and iii) the impact of interest from derivatives associated with notes payable, which is reclassified to interest expense as a component of total adjusted expenses. The Company considers adjusted net investment gains and losses important as it represents the remainder amount that is considered outside management's control, while excluding the components that are within management's control and are accordingly reclassified to net investment income and interest expense. The most comparable U.S. GAAP financial measure for adjusted net investment gains and losses is net investment gains and losses.

RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS
(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)
THREE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Net earnings $      303 $   1,639 (81.5) %
Items impacting net earnings:
Adjusted net investment (gains) losses 1,026 (335)
Other and non-recurring (income) loss — 1
Income tax (benefit) expense on items excludedfrom adjusted earnings (166) 22
Tax valuation allowance 51 —
Adjusted earnings 1,214 1,327 (8.5) %
Current period foreign currency impact1 14 N/A
Adjusted earnings excluding current period foreign      currency impact2 $   1,228 $   1,327 (7.5) %
Net earnings per diluted share $     0.61 $     3.08 (80.2) %
Items impacting net earnings:
Adjusted net investment (gains) losses 2.06 (0.63)
Other and non-recurring (income) loss — —
Income tax (benefit) expense on items excludedfrom adjusted earnings (0.33) 0.04
Tax valuation allowance 0.10 —
Adjusted earnings per diluted share 2.43 2.49 (2.4) %
Current period foreign currency impact1 0.03 N/A
Adjusted earnings per diluted share excluding      current period foreign currency impact2 $     2.46 $     2.49 (1.2) %
1 Prior period foreign currency impact reflected as "N/A" to isolate change for current period only.
2 Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.
RECONCILIATION OF NET EARNINGS TO ADJUSTED EARNINGS
(UNAUDITED – IN MILLIONS, EXCEPT FOR PER-SHARE AMOUNTS)
NINE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Net earnings $ 2,147 $ 2,267 (5.3) %
Items impacting net earnings:
Adjusted net investment (gains) losses 1,029 966
Other and non-recurring (income) loss — 54
Income tax (benefit) expense on items excludedfrom adjusted earnings (229) (97)
Tax valuation allowance 51 —
Adjusted earnings 2,998 3,190 (6.0) %
Current period foreign currency impact1 49 N/A
Adjusted earnings excluding current period foreign      currency impact2 $ 3,047 $ 3,190 (4.5) %
Net earnings per diluted share $   4.24 $   4.21 0.7 %
Items impacting net earnings:
Adjusted net investment (gains) losses 2.03 1.79
Other and non-recurring (income) loss — 0.10
Income tax (benefit) expense on items excludedfrom adjusted earnings (0.45) (0.18)
Tax valuation allowance 0.10 —
Adjusted earnings per diluted share 5.92 5.92 — %
Current period foreign currency impact1 0.10 N/A
Adjusted earnings per diluted share excluding      current period foreign currency impact2 $   6.02 $   5.92 1.7 %
1 Prior period foreign currency impact reflected as "N/A" to isolate change for current period only.
2 Amounts excluding current period foreign currency impact are computed using the average foreign currency exchange rate for the comparable prior-year period, which eliminates fluctuations driven solely by foreign currency exchange rate changes.
RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES
(UNAUDITED – IN MILLIONS)
THREE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Net investment (gains) losses $   1,072 $     (275) 489.8 %
Items impacting net investment (gains) losses:
Amortized hedge costs (11) (13)
Amortized hedge income 14 20
Net interest income (expense) from derivatives associated     with certain investment strategies (49) (66)
Impact of interest from derivatives associated with     notes payable1 — (1)
Adjusted net investment (gains) losses $   1,026 $     (335) 406.3 %
1 Amounts are included with interest expenses that are a component of adjusted expenses.
RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME
(UNAUDITED – IN MILLIONS)
THREE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Net investment income $   1,003 $   1,067 (6.0) %
Items impacting net investment income:
Amortized hedge costs (11) (13)
Amortized hedge income 14 20
Net interest income (expense) from derivatives associated     with certain investment strategies (49) (66)
Adjusted net investment income $      957 $   1,008 (5.1) %
RECONCILIATION OF NET INVESTMENT (GAINS) LOSSES TO ADJUSTED NET INVESTMENT (GAINS) LOSSES
(UNAUDITED – IN MILLIONS)
NINE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Net investment (gains) losses $ 1,176 $ 1,109 6.0 %
Items impacting net investment (gains) losses:
Amortized hedge costs (38) (31)
Amortized hedge income 51 80
Net interest income (expense) from derivatives associated     with certain investment strategies (160) (195)
Impact of interest from derivatives associated with     notes payable1 — 3
Adjusted net investment (gains) losses $ 1,029 $   966 6.5 %
1 Amounts are included with interest expenses that are a component of adjusted expenses.
RECONCILIATION OF NET INVESTMENT INCOME TO ADJUSTED NET INVESTMENT INCOME
(UNAUDITED – IN MILLIONS)
NINE MONTHS ENDED SEPTEMBER 30, 2026 2025 % Change
Net investment income $ 2,943 $ 3,103 (5.2) %
Items impacting net investment income:
Amortized hedge costs (38) (31)
Amortized hedge income 51 80
Net interest income (expense) from derivatives associated     with certain investment strategies (160) (195)
Adjusted net investment income $ 2,796 $ 2,957 (5.4) %
RECONCILIATION OF U.S. GAAP BOOK VALUE TO ADJUSTED BOOK VALUE
(EXCLUDING FOREIGN CURRENCY REMEASUREMENT)
(UNAUDITED – IN MILLIONS, EXCEPT FOR SHARE AND PER-SHARE AMOUNTS)
SEPTEMBER 30, 2026 2025 % Change
U.S. GAAP book value $  29,283 $  28,688
Less:
Unrealized foreign currency translation gains (losses) (4,925) (4,504)
Unrealized gains (losses) on securities and derivatives (5,011) (1,717)
Effect of changes in discount rate assumptions 12,264 6,832
Pension liability adjustment 85 42
Total AOCI 2,413 653
Adjusted book value $  26,870 $  28,035
Less:
Foreign currency remeasurement gains (losses) 6,681 5,157
Adjusted book value excluding foreign currency remeasurement $  20,189 $  22,878
Number of outstanding shares at end of period (000) 495,651 525,710
U.S. GAAP book value per common share $   59.08 $   54.57 8.3 %
Less:
Unrealized foreign currency translation gains (losses) per      common share (9.94) (8.57)
Unrealized gains (losses) on securities and derivatives per      common share (10.11) (3.27)
Effect of changes in discount rate assumptions     per common share 24.74 13.00
Pension liability adjustment per common share 0.17 0.08
Total AOCI per common share 4.87 1.24
Adjusted book value per common share $   54.21 $   53.33 1.7 %
Less:
Foreign currency remeasurement gains (losses) per common      share 13.48 9.81
Adjusted book value excluding foreign currency remeasurement per      common share $   40.73 $   43.52 (6.4) %
RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE
(EXCLUDING IMPACT OF FOREIGN CURRENCY)
THREE MONTHS ENDED SEPTEMBER 30, 2026 2025
U.S. GAAP ROE - Net earnings1 4.1 % 23.5 %
Impact of excluding unrealized foreign currency translation gains (losses) (0.8) (5.4)
Impact of excluding unrealized gains (losses) on securities and derivatives (0.6) (2.2)
Impact of excluding effect of changes in discount rate assumptions 1.8 7.7
Impact of excluding pension liability adjustment — 0.1
Impact of excluding AOCI 0.4 0.1
U.S. GAAP ROE - less AOCI 4.4 23.5
Differences between adjusted earnings and net earnings2 13.4 (4.5)
Adjusted ROE - reported 17.8 19.1
Impact of excluding gains (losses) associated with foreign currency remeasurement3 5.9 4.0
Adjusted ROE, excluding foreign currency remeasurement 23.7 23.1
1 U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.
2 See separate reconciliation of net earnings to adjusted earnings.
3 Impact of gains/losses associated with foreign currency remeasurement is calculated by excluding the cumulative (beginning January 1, 2021) foreign  currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement.
RECONCILIATION OF U.S. GAAP RETURN ON EQUITY (ROE) TO ADJUSTED ROE
(EXCLUDING IMPACT OF FOREIGN CURRENCY)
NINE MONTHS ENDED SEPTEMBER 30, 2026 2025
U.S. GAAP ROE - Net earnings1 9.7 % 11.0 %
Impact of excluding unrealized foreign currency translation gains (losses) (1.8) (1.6)
Impact of excluding unrealized gains (losses) on securities and derivatives (1.2) (0.3)
Impact of excluding effect of changes in discount rate assumptions 3.7 1.5
Impact of excluding pension liability adjustment — —
Impact of excluding AOCI 0.7 (0.4)
U.S. GAAP ROE - less AOCI 10.4 10.6
Differences between adjusted earnings and net earnings2 4.1 4.3
Adjusted ROE - reported 14.6 14.9
Impact of excluding gains (losses) associated with foreign currency      remeasurement3 4.3 3.5
Adjusted ROE, excluding foreign currency remeasurement 18.9 18.4
1 U.S. GAAP ROE is calculated by dividing net earnings (annualized) by average shareholders' equity.
2 See separate reconciliation of net earnings to adjusted earnings.
3 Impact of gains/losses associated with foreign currency remeasurement is calculated by excluding the cumulative (beginning January 1, 2021) foreign currency gains/losses associated with i) foreign currency remeasurement and ii) sales and redemptions of invested assets. The impact is the difference of adjusted return on equity - reported compared with adjusted return on equity, excluding from shareholders' equity, gains/losses associated with foreign currency remeasurement.
EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS****1
(SELECTED PERCENTAGE CHANGES, UNAUDITED)
THREE MONTHS ENDED SEPTEMBER 30, 2026 IncludingCurrencyChanges ExcludingCurrencyChanges****2
Net earned premiums3 (2.0) % 2.1 %
Adjusted net investment income (5.1) (3.3)
Total benefits and expenses 0.9 6.0
Adjusted earnings (8.5) (7.5)
Adjusted earnings per diluted share (2.4) (1.2)
1 Refer to previously defined adjusted earnings, adjusted earnings per diluted share, and adjusted net investment income.
2 Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.
3 Net of reinsurance
EFFECT OF FOREIGN CURRENCY ON ADJUSTED RESULTS****1
(SELECTED PERCENTAGE CHANGES, UNAUDITED)
NINE MONTHS ENDED SEPTEMBER 30, 2026 IncludingCurrencyChanges ExcludingCurrencyChanges****2
Net earned premiums3 (3.5) % 0.1 %
Adjusted net investment income (5.4) (4.0)
Total benefits and expenses (2.9) 0.9
Adjusted earnings (6.0) (4.5)
Adjusted earnings per diluted share 0.0 1.7
1 Refer to previously defined adjusted earnings and adjusted earnings per diluted share, and adjusted net investment income.
2 Amounts excluding currency changes were determined using the same foreign currency exchange rate for the current period as the comparable period in the prior year, which eliminates dollar-based fluctuations driven solely from currency rate changes.
3 Net of reinsurance

GLOSSARY OF OPERATIONAL MEASURES

The Company defines the operational measures included in this document as follows:

  • Operating ratios are used to evaluate the Company's financial condition and profitability. Examples include: (1) Ratios to total adjusted revenues, which present expenses as percentage of total revenues and (2) Ratios to total premium, including benefit ratio. Operating ratios include: Benefit Ratio and Expense Ratio.

  • New annualized premium sales are sometimes referred to as new sales or sales. An operating measure that is not reflected on the Company's financial statements. New annualized premium sales generally represent annual premiums on policies and riders the Company sold and incremental increases from policy conversions that would be collected over a 12-month period assuming the policies remain in force for that entire period. For Aflac Japan, new annualized premium sales are determined by applications submitted during the reporting period. For Aflac U.S., new annualized premium sales are determined by applications that are issued during the reporting period. Policy conversions are defined as the positive difference in the annualized premium when a policy upgrades in the current reporting period. The Company believes that this metric is a key indicator of the Company's future source of earnings.

  • Premium persistency is the percentage of premiums remaining in force at the end of a period, usually one year, and presented on a trailing 12-month average basis. For example, 95% persistency would mean that 95% of the premiums in force at the beginning of a period are still in force at the end of the period. The Company believes that this metric is a key driver of in force levels, which is a key measure of the size of the Company's business and future sources of earnings.

FORWARD-LOOKING INFORMATION 

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those included in the forward-looking statements. Aflac Incorporated (the Parent Company) and its subsidiaries (collectively with the Parent Company, the Company) desire to take advantage of these provisions. This document contains cautionary statements identifying important factors that could cause actual results to differ materially from those projected herein, and in any other statements made by Company officials in communications with the financial community and contained in documents filed with or furnished to the Securities and Exchange Commission (SEC). Forward-looking statements are not based on historical information and relate to future operations, strategies, financial results or other developments. Furthermore, forward-looking information is subject to numerous assumptions, risks and uncertainties. In particular, statements containing words such as "expect," "anticipate," "believe," "goal," "objective," "strategy," "may," "should," "estimate," "intend," "project," "future," "will," "assume," "potential," "target," "outlook," "continue" or similar words as well as specific projections of future results, generally qualify as forward-looking. The Company undertakes no obligation to update such forward-looking statements, except as may be required by law.

The Company cautions readers that the following factors, in addition to other factors mentioned from time to time, could cause actual results to differ materially from those contemplated by the forward-looking statements:

  • difficult conditions in global capital markets and the economy, including inflation
  • defaults and credit downgrades of investments
  • global fluctuations in interest rates and exposure to significant interest rate risk
  • concentration of business in Japan
  • limited availability of acceptable Japanese yen-denominated investments
  • foreign currency fluctuations in the yen/dollar exchange rate
  • differing interpretations applied to investment valuations
  • significant valuation judgments in determination of expected credit losses recorded on the Company's investments
  • decreases in the Company's financial strength or debt ratings
  • decline in creditworthiness of other financial institutions
  • the Company's ability to attract and retain qualified sales associates, brokers, employees, and distribution partners
  • deviations in actual experience from pricing and reserving assumptions
  • ability to continue to develop and implement improvements in information technology systems and on successful execution of revenue growth and expense management initiatives
  • interruption in telecommunication, information technology and other operational systems, or a failure to maintain the security, confidentiality, integrity or privacy of sensitive data residing on such systems, and uncertainty regarding the impact of the incident involving unauthorized access to the Company's network in June 2025
  • subsidiaries' ability to pay dividends to the Parent Company
  • inherent limitations to risk management policies and procedures
  • operational risks of third-party vendors
  • tax rates applicable to the Company may change
  • failure to comply with restrictions on policyholder privacy and information security
  • extensive regulation and changes in law or regulation by governmental authorities
  • competitive environment and ability to anticipate and respond to market trends
  • catastrophic events, including, but not limited to, epidemics, pandemics, tornadoes, hurricanes, earthquakes, tsunamis, war or other military action, major public health issues, terrorism or other acts of violence, and damage incidental to such events
  • ability to protect the Aflac brand and the Company's reputation
  • ability to effectively manage key executive succession
  • changes in accounting standards
  • level and outcome of litigation or regulatory inquiries
  • allegations or determinations of worker misclassification in the United States

Analyst and investor contact - David A. Young, 706.596.3264; 800.235.2667 or [email protected]

Media contact - Ines Gutzmer, 762.207.7601 or [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aflac-incorporated-announces-third-quarter-2026-results-declares-fourth-quarter-dividend-302929781.html

SOURCE Aflac Incorporated

Categories: Press Releases

View all news

Email Alert Sign Up

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Aflac Incorporated, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Aflac Incorporated to send you the requested Investor Email Alert updates.

* Required

Email Address * Mailing Lists *

Press Releases
Events
Presentations
SEC Filings
End of Day Stock Quote

Email Alert Sign Up Confirmation

Quick Links

Investor Contact

Call Investor Relations

1.800.235.2667

Call Shareholder Services

1.800.227.4756

© 2026 AFLAC Incorporated

Disclaimer

Coverage underwritten by American Family Life Assurance Company of Columbus. Group coverage underwritten by Continental American Insurance Company, which is not licensed to solicit business in Guam, Puerto Rico, or the Virgin Islands. For groups sitused in California, group coverage is underwritten by Continental American Life Insurance Company. For individual coverage in New York or coverage for groups sitused in New York, coverage is underwritten by American Family Life Assurance Company of New York.

© 2019 Aflac Incorporated

Powered By Q4 Inc. 5.192.4.2 (opens in new window)

From humble plush beginnings to collectible-icon status, the Aflac Holiday Duck has spent 25 years proving that giving back never goes out of style. 

Fashion trends come and go. But for a quarter-century, one seasonal celebrity has stayed relevant by reinventing itself year after year: You guessed it, the Aflac Holiday Duck. As the beloved plush celebrates its 25th anniversary in 2026, it's worth looking back at a style journey that proves kindness is the ultimate fashion statement. 

"The Aflac Duck’s scarves may steal the spotlight each year, but his identity as a symbol of our corporate philanthropy remains constant. It is the unwavering thread that holds these collections together,” said Kathelen Amos, president of the Aflac Foundation and former Aflac marketing director who introduced the Aflac Holiday Duck program in 2001 as a way to raise funds for pediatric cancer and blood disorders research and treatment. The cause has been the supplemental insurance company’s philanthropic cornerstone for more than three decades.

The debut holiday plush, produced only one year after the company started its Aflac Duck television ads, embraced a classic, uncomplicated look. No frills. No elaborate accessories. Just a soft duck in a Santa hat and blue neckerchief, unaware of its future star power and the impact it would eventually have on the lives of countless children and families affected by cancer and blood disorders. 

As the years passed, the limited-edition Aflac Holiday Duck began experimenting with its   seasonal style. Reindeer antlers, elf hats, scarves and sweaters brought new personality to each edition.  Some years featured sporty accessories such as ice skates, skis and sleds. Others celebrated holiday traditions, including caroling and cookie baking. Each year offered a fresh look while remaining connected to the duck's larger purpose. 

The result: A growing community of collectors eager to add each new duck to their flock, along with increasing support for pediatric patients. Nearly $4.7 million in net proceeds has been raised to date, with 100% supporting pediatric cancer and blood disorders research and treatment at participating hospitals across the United States. 

It’s a new season, and the 2026 Aflac Holiday Duck has landed, cuddled in a vibrant green vest with a fur-lined hood and a sweet candy cane accent. The latest edition carries forward 25 years of thoughtful design, holiday creativity and charitable impact. 

And once again, as from the beginning, his best accessory isn’t a sharp fit or seasonal embellishment. What is it?

Purpose.

Because while the Aflac Holiday Duck’s outfits may turn heads, his mission changes lives.

Visit www.aflacchildhoodcancer.org to purchase the 2026 Aflac Holiday Duck. It is available while supplies last in 6-inch ($14) and 10-inch ($23) sizes.

Aflac's family of insurers includes American Family Life Assurance Company of Columbus and/or American Family Life Assurance Company of New York, and/or Continental American Insurance Company (CAIC) and/or Continental American Life Insurance Company.

WWHQ | 1932 Wynnton Road | Columbus, GA  31999

Z2600906 EXP 10/27

Share Page Close

Facebook Twitter Google+

© 2026 AFLAC INCORPORATED

VIEW LEGAL

Individual Policies:
Coverage underwritten by American Family Life Assurance Company of Columbus. In New York, coverage underwritten by American Family Life Assurance Company of New York. Direct to Consumer individual coverage underwritten by Tier One Insurance Company.

Aflac Worldwide Headquarters | Columbus, GA

Aflac Group Policies:
Continental American Insurance Company (CAIC), a proud member of the Aflac family of insurers, is a wholly-owned subsidiary of Aflac Incorporated and underwrites group coverage. CAIC is not licensed to solicit business in New York, Guam, Puerto Rico, or the Virgin Islands. For groups sitused in California, group coverage is underwritten by Continental American Life Insurance Company. For groups sitused in New York, coverage is underwritten by American Family Life Assurance Company of New York.

Aflac Group | Columbia, SC

“Aflac” may include American Family Life Assurance Company of Columbus, American Family Life Assurance Company of New York, Continental American Insurance Company (marketed as “Aflac Group”), Tier One Insurance Company, and any other affiliated companies (collectively, “Aflac”), as applicable to the entity from whom you receive insurance services.

© 2026 000

 (opens in a new window)

Prompts

AFLAC Incorporated (ticker AFL), listed in United States.

ETFs Holding AFLAC Incorporated

ETF Weight in ETF Shares Market value As of
DIVS 2.84% 9,308 $ 1.091M Jun 30, 2026
ADIV 2.58% 11,763 $ 1.379M Jun 30, 2026
HUSV 2.48% 11,119 $ 1.424M Nov 16, 2026
CCOR 2.39% 5,232 $ 666.975K Jul 31, 2026
SAMT 2.03% 151,467 $ 17.76M Jun 30, 2026
LYLD 2.00% 1,135 $ 144.69K Jul 31, 2026
SPCT 1.96% 10,330 $ 1.317M Jul 31, 2026
NLSI short -1.76% -714 $ -79.811K Sep 30, 2026
RDVI 1.62% 498,467 $ 63.36M Nov 11, 2026
WBIF 1.48% 2,956 $ 346.591K Jun 30, 2026
ESLV 1.33% 1,493 $ 190.328K Jul 31, 2026
PRAY 1.26% 8,450 $ 990.763K Jun 30, 2026
FDIV 1.08% 4,963 $ 632.683K Jul 31, 2026
SYLD 1.02% 79,873 $ 10.182M Jul 31, 2026
WBIG 1.00% 2,332 $ 273.427K Jun 30, 2026
ESUM 0.95% 13,633 $ 1.738M Jul 31, 2026
DIVL 0.91% 4,681 $ 548.847K Jun 30, 2026
JSTC 0.76% 17,586 $ 2.252M Nov 17, 2026
PAPI 0.54% 18,284 $ 2.144M Jun 30, 2026
ESLG 0.52% 953 $ 121.488K Jul 31, 2026
AVIE 0.52% 673 $ 86.198K Nov 16, 2026
SIXL 0.44% 7,303 $ 923.903K Nov 12, 2026
BTAL 0.42% 10,120 $ 1.187M Jun 30, 2026
DFLV 0.37% 224,945 $ 28.458M Nov 12, 2026
VFVA 0.33% 27,205 $ 3.152M Aug 31, 2026
FTHI 0.30% 58,674 $ 7.515M Nov 16, 2026
DFUV 0.26% 326,521 $ 41.308M Nov 12, 2026
AVSU 0.26% 9,750 $ 1.249M Nov 16, 2026
FLSP 0.26% 20,641 $ 2.42M Jun 30, 2026
GMOV 0.25% 2,352 $ 272.479K Aug 31, 2026
VFMF 0.24% 20,606 $ 2.387M Aug 31, 2026
DFSU 0.23% 43,291 $ 5.477M Nov 12, 2026
GEW 0.19% 2,422 $ 280.589K Aug 31, 2026
DXUV 0.17% 82,054 $ 10.381M Nov 12, 2026
AVUS 0.15% 170,033 $ 21.778M Nov 16, 2026
AVLC 0.15% 18,734 $ 2.399M Nov 16, 2026
FTLS 0.15% 31,089 $ 0.00 Nov 16, 2026
MODL 0.13% 11,566 $ 1.356M Jun 30, 2026
XMAG 0.13% 2,211 $ 279.714K Nov 13, 2026
LGDX 0.13% 1,426 $ 182.642K Nov 17, 2026
DFAC 0.12% 847,847 $ 107.261M Nov 12, 2026
DCOR 0.12% 412,258 $ 52.155M Nov 12, 2026
VFMV 0.11% 4,431 $ 513.331K Aug 31, 2026
SFGV 0.11% 10,186 $ 1.29M Nov 18, 2026
HBTA 0.11% 2,305 $ 267.034K Aug 31, 2026
DFAU 0.11% 109,664 $ 13.874M Nov 12, 2026
VOXP 0.09% 42 $ 5,354.16 Jul 31, 2026
NTSD 0.09% 279 $ 32.713K Jun 30, 2026
TACU 0.09% 129 $ 16.448K Nov 17, 2026
NTSX 0.09% 10,170 $ 1.192M Jun 30, 2026
GDE 0.09% 3,548 $ 411.036K Aug 31, 2026
DFUS 0.08% 142,023 $ 17.967M Nov 12, 2026
APUE 0.07% 15,699 $ 1.819M Aug 31, 2026
HCMT 0.07% 3,187 $ 406.279K Jul 31, 2026
AAUS 0.07% 2,632 $ 330K Nov 18, 2026
IQSZ 0.07% 899 $ 114.605K Jul 31, 2026
WSGE 0.06% 264 $ 33.549K Nov 18, 2026
ACVF 0.06% 680 $ 86.686K Jul 31, 2026
DFVX 0.05% 2,412 $ 305.142K Nov 12, 2026
MSLC 0.05% 18,532 $ 2.147M Aug 31, 2026
AFLG 0.05% 3,851 $ 493.236K Nov 16, 2026
CSHP 0.03% 946 $ 121.164K Nov 16, 2026
GSPY 0.03% 1,525 $ 195.322K Nov 17, 2026
VSLU 0.03% 1,273 $ 149.259K Jun 30, 2026
EBI 0.01% 794 $ 91.985K Aug 31, 2026
NPFE 0.00% 56 $ 7,138.88 Jul 31, 2026
CORO 0.00% 281 $ 36.045K Nov 16, 2026
NTRL short 0.00% -1,713 $ 0.00 Nov 16, 2026

Securities

Ticker Type Class Market Exchange Last price Price date
AFL canonical Common share — US nyse 128.38 USD 2026-11-16
8686 Common share — JP tsej — —